We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Criteria for Diagnosing Celiac Disease May Be Too Stringent

By Labmedica staff writers
Posted on 29 May 2008
Current diagnostic criteria for celiac disease include small intestinal mucosal membrane villus atrophy and inflammation. More...
According to new evidence, these criteria may be too stringent, leaving patients with the disease undiagnosed and untreated.

Celiac disease is an autoimmune disorder in the small intestine triggered by the consumption of a common protein called gluten--found in bread, pasta, and many other common foods. Though the disease is genetic, it often goes undiagnosed. Symptoms of gluten toxicity include diarrhea, weight loss, abdominal pain, anemia, and oral ulcerations. While most people with celiac disease do well on a gluten-free diet, the level of gluten avoidance needed to maintain disease remission represents a significant burden

To determine if the current diagnostic criteria are too narrow, 145 patients suspected of having celiac disease were examined. Seventy-one of the patients were found to be endomysial antibody-positive, and of those only 48 met the criteria under the current definition of celiac disease. The remaining 23 patients were divided randomly into two groups. One group was placed on a gluten-free diet and the other continued a regular diet that included gluten.

Patients were biopsied again after one year following their respective diets. Patients on the gluten-free diet were asymptomatic and their endomysial antibodies disappeared, as did their small intestinal mucosal inflammation. However, the patients on a regular diet continued to experience symptoms. These patients continued to be endomysial antibody-positive and showed further deterioration of the small bowel membrane, mucosal inflammation, and gluten-induced lesions in the bowel.

According to Markku Maki, M.D., professor of pediatrics at the University of Tampere, Celiac Disease Study Group (UTa, Tampere, Finland) patients on the gluten-free diet elected to continue the diet after the yearlong study, and the patients on the regular diet elected to eliminate gluten from their diet and over time became symptom free, endomysial antibody-free, and experienced healing of the mucosal membrane.

Scientists believe that over time, patients who are endomysial antibody-positive may develop the gut injury that makes up the current criteria for diagnosing celiac disease. "By redefining the criteria for celiac disease, we can treat patients before they begin to experience the most severe symptoms and signs of the disease,” said Dr. Maki.

This study was presented at the Digestive Disease Week (DDW) in San Diego (CA, USA) which took place from May 17-22, 2008.


Related Links:
University of Tampere

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.